{
  "id": 21190182,
  "title": "İlaç firmalarına yeni kurallar: Piyasada bulunmayan ilaçların tanıtımı yasaklandı",
  "url": "https://urgent.news/2026/11/22/ilac-firmalar-na-yeni-kurallar-piyasada-bulunmayan-ilaclar-n-tan-t-m",
  "topic": "world",
  "section": "World",
  "published": "2026-11-22T07:21:00.000Z",
  "source": {
    "name": "BirGün",
    "slug": "birgun",
    "url": "https://www.birgun.net/haber/ilac-firmalarina-yeni-kurallar-piyasada-bulunmayan-ilaclarin-tanitimi-yasaklandi-747754"
  },
  "original_language": "pt",
  "account": "New regulations have been put in place for pharmaceutical companies, banning the promotion of drugs that are not yet available on the market in Turkey. The amendment, published in the Official Gazette on November 21, 2023, updates the Guidelines for Advertising of Non-Pharmaceutical Products, which were released by the Turkish State Hospital and Medical Devices Authority (TİTCK). The regulation now includes pharmaceutical products that lack any presence in the market, even if they are registered or licensed. This change expands the scope of the ban on promoting unregistered or unlicensed drugs to encompass those that are not present in the Turkish market. The amendment also revises the reporting periods for scientific meetings and visits to production facilities, requiring pharmaceutical companies to notify TİTCK at least five business days before domestic meetings and at least ten business days before international conferences. Additionally, visits to production facilities are now considered part of promotional activities and will be evaluated accordingly. The regulation does not directly ban the sale of medications or revoke licenses; it focuses on regulating promotional activities aimed at healthcare professionals. The new guidelines, effective from November 21, 2023, aim to ensure compliance with the rules for promotional activities directed at healthcare professionals.",
  "summary": "Türkiye İlaç ve Tıbbi Cihaz Kurumu, ilaç firmalarının tanıtım faaliyetlerine ilişkin yönetmeliği değiştirdi. Türkiye'de ruhsatlı veya izinli olmasına rağmen piyasada bulunmayan ilaçların sağlık çalışanlarına yönelik tanıtımı yasak kapsamına alındı. Bilimsel toplantıların bildirim süreleri de yeniden düzenlendi.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}